AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

14,124.00p
   
  • Change Today:
    -222.00p
  • 52 Week High: 14,410.00p
  • 52 Week Low: 9,667.00p
  • Currency: UK Pounds
  • Shares Issued: 1,550.91m
  • Volume: 502,675
  • Market Cap: £219,050m
  • RiskGrade: 123
  • Beta: 1.19

Latest ShareCast News

Director/PDMR Shareholding

By Sharecast

Date: Monday 22 Dec 2025

AstraZeneca ShareCast News

AstraZeneca gets fresh designation for Enhertu w... 22-Dec-2025 ShareCast
Enhertu granted BTD for post-neoadjuvant early BC 22-Dec-2025 ShareCast
Update on LATIFY Phase III trial of ceralasertib 22-Dec-2025 ShareCast
Director/PDMR Shareholding 19-Dec-2025 ShareCast
AstraZeneca chalks up dual regulatory wins in ca... 16-Dec-2025 ShareCast

AstraZeneca Regulatory News

AZN new Head of Investor Relations Joris Silon 08-Jan-2026 07:00 RNS
Total Voting Rights 02-Jan-2026 15:00 RNS
Director/PDMR Shareholding 22-Dec-2025 11:00 RNS
Director/PDMR Shareholding 22-Dec-2025 11:00 RNS
Enhertu granted BTD for post-neoadjuvant early BC 22-Dec-2025 07:30 RNS

AstraZeneca Newspaper Links

Fighting Frenchman shows us how as he ensures As... 30-Dec-2014 Daily Mail
Exclusive: UK firms vie for share of £170bn in A... 08-Dec-2014 The Independent
MARKET REPORT: Ariad on the up amid growing spec... 04-Dec-2014 Daily Mail
Some reasons why Pfizer won’t bid for AstraZenec... 19-Nov-2014 Guardian
Pfizer unlikely to try AstraZeneca takeover agai... 07-Nov-2014 Guardian

AstraZeneca Tips & Analysis

Questor :AstraZeneca 29-Apr-2014 Telegraph
Questor : AstraZeneca 24-Jan-2014 Telegraph
Questor:AstraZeneca 22-Dec-2011 Telegraph
Investment Column:AstraZeneca 28-Oct-2011 The Independent
Investment Column: AstraZeneca 23-Jun-2011 The Independent

AstraZeneca News Wires

MedImmune Announces Zook as President 13-Nov-2008 PR Newswire
Survey Shows Lung Cancer Patients Blamed for The... 12-Nov-2008 PR Newswire
CRESTOR Demonstrates Dramatic CV Risk Reduction ... 09-Nov-2008 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 14,124.00p
Change Today -222.00p
% Change -1.55 %
52 Week High 14,410.00p
52 Week Low 9,667.00p
Volume 502,675
Shares Issued 1,550.91m
Market Cap £219,050m
Beta 1.19
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average
90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average
Price Trend
9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Income
68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 07-Aug-25 20-Feb-25
Paid 08-Sep-25 24-Mar-25
Amount 103.00¢ 210.00¢

Trades for 15-Jan-2026

Time Volume / Share Price
15:11 15 @ 14,124.00p
15:11 37 @ 14,122.00p
15:11 23 @ 14,122.00p
15:11 53 @ 14,120.00p
15:11 25 @ 14,120.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page